Sinphar Pharmaceutical Co Ltd banner

Sinphar Pharmaceutical Co Ltd
TWSE:1734

Watchlist Manager
Sinphar Pharmaceutical Co Ltd Logo
Sinphar Pharmaceutical Co Ltd
TWSE:1734
Watchlist
Price: 30.65 TWD -0.33% Market Closed
Market Cap: NT$5.8B

Profitability Summary

Sinphar Pharmaceutical Co Ltd's profitability score is 51/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

51/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

51/100
Profitability
Score
51/100
Profitability
Score

Margins

Earnings Waterfall
Sinphar Pharmaceutical Co Ltd

Margins Comparison
Sinphar Pharmaceutical Co Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
TW
Sinphar Pharmaceutical Co Ltd
TWSE:1734
5.8B TWD
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
947.5B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
593.4B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
282B CHF
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
244.9B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
231.2B GBP
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
298.6B USD
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1T DKK
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
151.7B USD
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
123.9B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Sinphar Pharmaceutical Co Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
TW
Sinphar Pharmaceutical Co Ltd
TWSE:1734
5.8B TWD
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
947.5B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
593.4B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
282B CHF
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
244.9B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
231.2B GBP
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
298.6B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
151.7B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
123.9B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Sinphar Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett